NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/04/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization4.47 mln
Float0.05 mln
Earnings Date04/24/2025
EPS
3,157
Exceptional
P / E
0.00
Anomalous
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
31.13
Highly suspicious
Relative Strength
99
/ 100
Top performer
Debt / Equity
-2.70
Negative equity
Business Description
SciSparc Ltd. is an Israel-based pharmaceutical company focused on developing treatments derived from cannabinoid compounds, targeting conditions such as Tourette syndrome, Alzheimer's disease, autism spectrum disorder, and chronic pain. The company works with manufacturing and research partners to bring its pipeline of drug candidates through clinical trials and toward commercial production. In addition to its drug development work, SciSparc sells hemp seed oil-based consumer products. Founded in 2004 and headquartered in Tel Aviv, the company was previously known as Therapix Biosciences Ltd. before rebranding in 2021.
